Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Slayden

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|December 26, 2008
Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosisRichard A Slayden, John T Belisle
Plos Neglected Tropical Diseases|January 13, 2017
Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment ResponseJason E Cummings, Richard A Slayden
Future Microbiology|December 9, 2024
Targeted enzymes delivered by liposomes could address an unmet need in mycobacterial respiratory infectionsJason W Holder, Richard A Slayden
BMC Microbiology|April 21, 2011
Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress responseKathleen England, Rebecca Crew, Richard A Slayden
Current Topics in Medicinal Chemistry|March 10, 2007
Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosisPeter J Tonge, Caroline Kisker, Richard A Slayden
Jac-Antimicrobial Resistance|March 30, 2022
Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against Category A and B priority pathogensJason E Cummings, Zaid Abdo, Richard A Slayden
BMC Bioinformatics|February 17, 2026
Transfer learning models for bacterial strain dissemination biomarkers using weighted non-parallel proximal support vector machinesUgochukwu O Ugwu, Richard A Slayden, Michael Kirby
Jac-Antimicrobial Resistance|July 5, 2021
TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogen <i>Francisella tularensis</i>Jason E Cummings, Keaton W Slayden, Richard A Slayden
Pathogens and Disease|May 23, 2018
Toxin-antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosisRichard A Slayden, Clinton C Dawson, Jason E Cummings
Frontiers in Immunology|April 19, 2013
The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infectionAlan Rowe Schenkel, Luke C Kingry, Richard A Slayden
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|December 26, 2008
Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosisRichard A Slayden, John T Belisle
Plos Neglected Tropical Diseases|January 13, 2017
Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment ResponseJason E Cummings, Richard A Slayden
Future Microbiology|December 9, 2024
Targeted enzymes delivered by liposomes could address an unmet need in mycobacterial respiratory infectionsJason W Holder, Richard A Slayden
BMC Microbiology|April 21, 2011
Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress responseKathleen England, Rebecca Crew, Richard A Slayden
Current Topics in Medicinal Chemistry|March 10, 2007
Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosisPeter J Tonge, Caroline Kisker, Richard A Slayden
Jac-Antimicrobial Resistance|March 30, 2022
Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against Category A and B priority pathogensJason E Cummings, Zaid Abdo, Richard A Slayden
BMC Bioinformatics|February 17, 2026
Transfer learning models for bacterial strain dissemination biomarkers using weighted non-parallel proximal support vector machinesUgochukwu O Ugwu, Richard A Slayden, Michael Kirby
Jac-Antimicrobial Resistance|July 5, 2021
TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogen <i>Francisella tularensis</i>Jason E Cummings, Keaton W Slayden, Richard A Slayden
Pathogens and Disease|May 23, 2018
Toxin-antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosisRichard A Slayden, Clinton C Dawson, Jason E Cummings
Frontiers in Immunology|April 19, 2013
The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infectionAlan Rowe Schenkel, Luke C Kingry, Richard A Slayden
Pageof 8